Purchase Order 75N91024P00152
Award Date 1/5/24
Potential Completion Date 3/5/24
Potential Value $17K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Prairie Rose, ND 58104, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $18,401.04 firm fixed price purchase order awarded by the Department of the Interior U.S. Geological Survey Office of Acquisitions and Grants to Aldevron, L.L.C., a small business manufacturer of biologicals. The contract is for the delivery of recombinant monoclonal antibodies, with performance in Fargo, North Dakota. While Aldevron has previously supported federal contracts related to infectious disease and cancer research at agencies like the National Institutes of Health, this...
- This federal contract award, identified as HHSN272201400873P, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The $7,335.00 firm-fixed-price purchase order was awarded to Aldevron, L.L.C., a for-profit limited liability company and manufacturer of biological products, to provide 15 units of AMBIS 1695546 PLASMID PREP, 3MG, CAT # 3000, at a...
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $14,399.52 firm fixed price purchase order to Bio-Techne Sales Corporation of Minneapolis, Minnesota. Under this contract, Bio-Techne will provide fetal bovine serum to support the NIH National Cancer Institute's research efforts. The one year contract runs from July 20, 2023 through July 19, 2024 and was awarded without any set aside designations. Bio-Techne will serve as the prime...
- This federal contract award, valued at $98,077.50, was issued by the National Cancer Institute (NCI), an agency within the U.S. Department of Health and Human Services, to Sartorius Stedim North America Inc. The contract is for the purchase of CellGenix GMP rh IL-4 50ug vials to support cancer vaccine research and clinical trials conducted by the NCI's Center for Cancer Research, Vaccine Branch. This is a firm fixed-price purchase order contract with a completion date of September 30, 2022....
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $19,961.98 purchase order to Cell Culture Collective, Inc. for fetal bovine serum. Cell Culture Collective, Inc. will deliver the requested serum to support biomedical research efforts under this firm fixed price contract. Performance will take place in Encinitas, California over a one-month period concluding in late September 2023. No set aside designation or subcontractors were...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $13,790 firm fixed price delivery order to Illumina, Inc. for biological kits. The award was issued under an unspecified governmentwide acquisition contract vehicle. The prime contractor Illumina will provide the kits to support the National Cancer Institute's research efforts. The place of performance is Illumina's facility in San Diego, California. The period of performance is one...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $13,128 purchase order to Advanced Cell Diagnostics, Inc., doing business as ACD, for reagents. ACD is a division of Bio-Techne Corporation, doing business as Bio-Techne. The firm fixed price order runs from July 31, 2023 through August 31, 2023 for delivery to ACD's Newark, California facility. No additional details were provided on the original solicitation, major subcontractors, or...
- The National Cancer Institute awarded a $14,976 firm fixed-price Blanket Purchase Agreement (BPA) call to Research and Diagnostic Systems, Inc. (R&D Systems) on August 18, 2021, for the supply of Fetal Bovine Serum – Optima, with performance completion by September 30, 2021. The award was made through open competition with no set-aside designation. R&D Systems, a Minneapolis-based manufacturer of biological research materials and subsidiary of Bio-Techne Corporation, specializes in...
- The National Cancer Institute awarded a $24.9K firm fixed-price contract to Research and Diagnostic Systems, Inc. (R&D Systems) on May 25, 2021, for the purchase of eighty-three 500 ml bottles of fetal bovine serum, Lot #K19150. This contract was executed as a call against an existing Blanket Purchase Agreement and represents a non-competitive procurement. The place of performance is Minneapolis, Minnesota, where R&D Systems maintains its headquarters as a subsidiary of Bio-Techne...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $24,671 purchase order to Bio-Rad Laboratories, Inc. Life Science Group Division for a service agreement for digital PCR instruments. As the prime contractor, Bio-Rad will provide services and support for digital PCR instruments located at the National Cancer Institute in Rockville, Maryland over a one year period from November 2023 through November 2024. The contract is a firm fixed...